dBET1 represents a proteolysis-targeting chimera (PROTAC) targeted against BET family members (73), and targeted BRD4 degradation in acute myeloid leukemia (AML) by dBET1 specifically impairs MYC transcription. The gene discussed is MYC; the disease is acute myeloid leukemia.